$55 BillionThe market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.
$2 BillionTotal revenue in the last quarter.
$-147 MillionNet income is all revenues minus all expenses including taxes and interest in the last quarter.
$2.86Earnings per share is the amount of net income that is attributed to each single share outstanding.
-Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).
13.46xThe price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.
$-61 MillionEarnings before interest expenses and taxes in the last quarter.
36,000The number of full time employees.
Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical specialties. It operates through the following segments: Cardiovascular, Rhythm Management, and MedSurg. The Cardiovascular segment comprises of technologies or diagnosing and treating coronary artery disease, and other cardiovascular disorders including structural heart conditions. The Rhythm Management segment develops implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. The MedSurg segment focuses on Endoscopy, which provides devices to diagnose and treat a broad range of gastrointestinal, and pulmonary conditions with innovative and invasive technologies. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.
Due to the pandemic, we have included a special section on the Impact of COVID 19 on the Electroceuticals Bioelectric Medicine Market which would mention How the Covid-19 is affecting the Electroce...OpenPR, about 8 hours ago
Data Bridge Market Research has recently added a concise research on the Global Insertable Cardiac Monitors (ICM) Market - Industry Trends and Forecast to 2026. GLOBAL INSERTABLE CARDIAC MONITORS (...OpenPR, 3 days ago
Boston Scientific Corp, after being sanctioned for discovery violations in a whistleblower lawsuit over allegedly defective defibrillators and ordered to pay the plaintiff's legal fees for the sanc...Reuters, 6 days ago